VTC Innovation

VTC Innovation is a Vietnamese biotechnology and technology company that gained prominence for its development of domestic vaccine candidates during the COVID-19 pandemic. The company focuses on leveraging advanced molecular biology and mRNA technology to address infectious diseases and public health challenges in Southeast Asia. Its lead program, VTC-101, is an mRNA-based vaccine candidate designed to provide protection against SARS-CoV-2 variants. Beyond vaccine development, VTC Innovation integrates digital health solutions and technology-driven research to streamline clinical development and manufacturing processes. The company represents a significant part of Vietnam's effort to establish self-sufficiency in high-tech biopharmaceutical production.